Back to search

Boston University

Biomarkers in graft versus host disease after allogeneic hematopoietic stem cell transplant

Abstract

dc:description.abstract

Hematopoietic stem cell transplant was developed as a curative therapy to treat onco-hematological diseases and recently indications for this therapy have expanded to include solid tumors, hemoglobinopathies and other genetic diseases and disorders. Two major types of hematopoietic stem cell transplant have been developed. Autologous transplants aim to deliver a massive dose of radiation and/or chemotherapy that is capable of ablating the hematopoietic stem cells in the bone marrow. The patient is then "rescued" from this lethal dose of treatment by an infusion of their own hematopoietic stem cells. Allogeneic transplants are designed to either functionally replace a cell class, or an enzyme or biological function absent in the patient, or to consolidate a remission in a onco-hematological disease via the graft-versus-tumor effect . Two of the largest causes of non-relapse mortality from an allogeneic hematopoietic stem cell transplant are acute and chronic graft-versus-host disease, in which immune cells derived from the graft recognize normal host tissue as foreign and attack these tissues. A host of biomarkers for acute graft versus host disease have been identified, but there is almost none for chronic graft versus host disease. Herein, a methodology to discover and validate a biomarker(s) for the most common organ system affected by chronic graft versus host disease is proposed.

Degree

thesis:*
Name thesis:degree_name
M.A.
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Geary, Joshua J.

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/16011

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Geary, Joshua J.. Biomarkers in graft versus host disease after allogeneic hematopoietic stem cell transplant. masters thesis, Boston University, 2015. https://hdl.handle.net/2144/16011